Advertisement

Breast Cancer Research and Treatment

, Volume 178, Issue 1, pp 199–205 | Cite as

Risk of breast cancer among women with benign ovarian tumors: a Danish nationwide cohort study

  • Mathilde Gottschau
  • Allan Jensen
  • Kristian Reinholdt
  • Sonia Guleria
  • Christian Munk
  • Lene Mellemkjær
  • Susanne K. KjærEmail author
Epidemiology

Abstract

Purpose

To assess the association between benign ovarian tumors and subsequent risk of breast cancer, and to examine this association according to type of benign ovarian tumors.

Methods

This nationwide cohort study comprised all Danish women diagnosed with a benign ovarian tumor during 1978–2016 (n = 158,221) identified through the Danish National Patient Register. The cohort was linked to the Danish Cancer Registry to identify all cases of breast cancer, and standardized incidence ratios (SIR) and 95% confidence intervals (CI) were calculated.

Results

Overall, women with a benign ovarian tumor were at significantly increased risk of breast cancer. The risk was confined to women with a solid ovarian tumor (SIR 1.09; 95% CI 1.05–1.13), particularly in women ≥ 50 years at benign tumor diagnosis (SIR 1.19; 95% CI 1.12–1.26). The risk remained increased up to 20 years or more after the diagnosis of a solid ovarian tumor (SIR 1.11; 95% CI 1.04–1.18), and women with a solid tumor were at increased risk of ductal, lobular, and other types of breast cancer, although most consistent for the lobular subtype. For cystic tumors, this association was confined to ductal breast cancer in women with the tumor diagnosed at age ≥ 50 years.

Conclusions

Women with a benign ovarian tumor were at increased risk of breast cancer. This association was largely confined to women with a solid ovarian tumor, and the excess risk was present 20 years or more after the ovarian tumor diagnosis. The underlying mechanism is unknown and should be investigated further.

Keywords

Benign ovarian tumors Ovarian cysts Breast cancer Cohort study Denmark 

Notes

Acknowledgement

We wish to thank Lea Elsborg Hansen Olsen for help with data management.

Author contributions

AJ and SKK initiated and designed the study. MG and KR performed the literature search. MG drafted the manuscript. All authors critically revised subsequent drafts. All authors read and approved the submitted version and take full responsibility for the content of the manuscript.

Funding

No funding was obtained for this project.

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

In Denmark, informed consent is not required for register-based studies.

References

  1. 1.
  2. 2.
    Engholm G, Ferlay J, Christensen N, Hansen H L, Hertzum-Larsen R, Johannesen T B, et al NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic Countries, Version 8.1 (28.06.2018). Association of the Nordic Cancer Registries, Danish Cancer Society. http://www.ancr.nu. Accessed 12 Dec 2018
  3. 3.
    Jensen MB, Ejlertsen B, Mouridsen HT, Christiansen P, for the Danish Breast Cancer Cooperative Group (2016) Improvements in breast cancer survival between 1995 and 2012 in Denmark: the importance of earlier diagnosis and adjuvant treatment. Acta Oncol 55(Suppl 2):24–35Google Scholar
  4. 4.
    Anderson WF, Pfeiffer RM, Dores GM, Sherman ME (2006) Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomark Prev 15(10):1899–1905CrossRefGoogle Scholar
  5. 5.
    McPherson K, Steel CM, Dixon JM (2000) ABC of breast diseases: breast cancer—epidemiology, risk factors and genetics. BMJ 321(7261):624–628CrossRefGoogle Scholar
  6. 6.
    Dossus L, Benusiglio PR (2015) Lobular breast cancer: incidence and genetic and non-genetic risk factors. Breast Cancer Res 17:37CrossRefGoogle Scholar
  7. 7.
    McDonald JM, Modesitt SC (2006) The incidental postmenopausal adnexal mass. Clin Obstet Gynecol 49(3):506–516CrossRefGoogle Scholar
  8. 8.
    Booth M, Beral V, Maconochie N, Carpenter L, Scott C (1992) A case-control study of benign ovarian tumours. J Epidemiol Community Health 46:528–531CrossRefGoogle Scholar
  9. 9.
    Greenlee RT, Kessel B, Williams CR, Riley TL, Ragard LR, Hartge P et al (2010) Prevalence, incidence and natural history of simple ovarian cysts among women over age 55 in a large cancer screening trial. Am J Obstet Gynecol 202(4):373CrossRefGoogle Scholar
  10. 10.
    Christensen JT, Boldsen JL, Westergaard JG (2002) Functional ovarian cysts in premenopausal and gynecologically healthy women. Contraception 66(3):153–157CrossRefGoogle Scholar
  11. 11.
    Parazzini F, Moroni S, Negri E, Crosignani PG (1996) Risk factors for seromucinous benign ovarian cysts in northern Italy. J Epidemiol Community Health 51:449–452CrossRefGoogle Scholar
  12. 12.
    Parazzini F, Moroni S, Negri E, La Vecchia C, Dal Pino D, Ricci E (1996) Risk factors for functional ovarian cysts. Epidemiology 7(5):547–549CrossRefGoogle Scholar
  13. 13.
    Sharma A, Gentry-Maharaj A, Burnell M, Fourkala E, Campbell S, Amso N et al (2012) Assessing the malignant potential of ovarian inclusion cysts in postmenopausal women within the UK collaborative trial of ovarian cancer screening (UKCTOCS): a prospective cohort study. BJOG 119(2):207–219CrossRefGoogle Scholar
  14. 14.
    Borgfeldt C, Andolf E (2004) Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. Acta Obstet Gynecol Scand 83:395–400CrossRefGoogle Scholar
  15. 15.
    Franceschi S, La Vecchia C, Negri E, Parazzini F, Boyle P (1990) Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 26(7):781–785CrossRefGoogle Scholar
  16. 16.
    Schairer C, Persson I, Falkeborn M, Naessen T, Troisi R, Brinton LA (1997) Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer 70:150–154CrossRefGoogle Scholar
  17. 17.
    Moseson M, Koenig KL, Shore RE, Pasternack BS (1993) The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 22(6):1000–1009CrossRefGoogle Scholar
  18. 18.
    Knight JA, Lesosky M, Blackmore KM, Voigt LF, Holt VL, Bernstein L et al (2008) Ovarian cysts and breast cancer: results from the Women’s Contraceptive and Reproductive Experiences Study. Breast Cancer Res Treat 109(1):157–164CrossRefGoogle Scholar
  19. 19.
    Knight JA, John EM, Milne RL, Dite GS, Balbuena R, Shi EJ et al (2006) An inverse association between ovarian cysts and breast cancer in the Breast Cancer Family Registry. Int J Cancer 118(1):197–202CrossRefGoogle Scholar
  20. 20.
    Bosetti C, Scotti L, Negri E, Talamini R, Levi F, Franceschi S et al (2006) Benign ovarian cysts and breast cancer risk. Int J Cancer 119(7):1679–1682CrossRefGoogle Scholar
  21. 21.
    Talamini R, Franceschi S, Favero A, Negri E, La Vecchia C (1997) Selected medical conditions and risk of breast cancer. Br J Cancer 75(11):1699–1703CrossRefGoogle Scholar
  22. 22.
    Jung SJ, Song M, Choi JY, Song N, Park SK, Yoo KY et al (2013) Association of selected medical conditions with breast cancer risk in Korea. J Prev Med Public Health 46(6):346–352CrossRefGoogle Scholar
  23. 23.
    Weiss HA, Brinton LA, Potischman NA, Brogan D, Coates RJ, Gammon MD et al (1999) Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 28:816–823CrossRefGoogle Scholar
  24. 24.
    Lynge E, Sandegaard JL, Rebolj M (2011) The Danish national patient register. Scand J Public Health 39(7 Suppl):30–33CrossRefGoogle Scholar
  25. 25.
    Pedersen CB (2011) The Danish civil registration system. Scand J Public Health 39(7 Suppl):22–25CrossRefGoogle Scholar
  26. 26.
    Gjerstorff ML (2011) The Danish cancer registry. Scand J Public Health 39(7 Suppl):42–45CrossRefGoogle Scholar
  27. 27.
    Ressing M, Blettner M, Klug SJ (2010) Data analysis of epidemiological studies: part 11 of a series on evaluation of scientific publications. Dtsch Arztebl Int 107(11):187–192PubMedPubMedCentralGoogle Scholar
  28. 28.
    Breslow NE, Day NE (1987) Rates and rate standardization. Statistical methods in cancer research—volume II: the design and analysis of cohort studies. IARC Scientific Publications No 82. International Agency for Research on Cancer, pp 48–79Google Scholar
  29. 29.
    Soegaard M, Kjaer SK, Cox M, Wozniak E, Hogdall E, Hogdall C et al (2008) BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark. Clin Cancer Res 14(12):3761–3767CrossRefGoogle Scholar
  30. 30.
    Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A (2001) Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst 93(16):1215–1223CrossRefGoogle Scholar
  31. 31.
    Ehrmann DA (2005) Polycystic ovary syndrome. N Engl J Med 352:1223–1236CrossRefGoogle Scholar
  32. 32.
    Barry JA, Azizia MM, Hardiman PJ (2014) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 20(5):748–758CrossRefGoogle Scholar
  33. 33.
    Gottschau M, Kjaer SK, Jensen A, Munk C, Mellemkjaer L (2015) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study. Gynecol Oncol 136(1):99–103CrossRefGoogle Scholar
  34. 34.
    Metindir J, Aslan S, Bilir G (2005) Ovarian cyst formation in patients using tamoxifen for breast cancer. Jpn J Clin Oncol 35(10):607–611CrossRefGoogle Scholar
  35. 35.
    Clemons M, Goss P (2001) Estrogen and the risk of breast cancer. N Engl J Med 344(4):276–285CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Mathilde Gottschau
    • 1
  • Allan Jensen
    • 1
  • Kristian Reinholdt
    • 1
  • Sonia Guleria
    • 1
  • Christian Munk
    • 1
  • Lene Mellemkjær
    • 1
  • Susanne K. Kjær
    • 1
    • 2
    Email author
  1. 1.Unit of Virus, Lifestyle and GenesDanish Cancer Society Research CenterCopenhagenDenmark
  2. 2.Department of Gynecology, RigshospitaletUniversity of CopenhagenCopenhagenDenmark

Personalised recommendations